Live Quote · NASDAQARCTHealthcare· Biotechnology

Arcturus Therapeutics Holdings Inc.

$7.45▼ 1.97%($-0.15)
MKT CAP $214.73MNEXT EARNINGS Mar 2, 2027
50%
Bullish
TickerSpark Score
55/100
▌ Mixed
70
Valuation
40
Profitability
50
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ARCT research report →

Analyst Price Target
$30.50+309.4% vs. today

Range $20 – $41

Analyst RatingBuy
12 Buy5 Hold4 Sell

Price Chart

+26.27% · this period
$16.93$11.23$5.53Nov 20May 26Nov 20
52-Week Range16% of range
Low
$5.50
Current
$7.45
High
$17.96